Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Bromocriptine

3

V.a Pleural effusion (uni- or bilateral) (can accompany DI-LDs)

2
Last update : 09/07/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist
See also under
Ergots, ergot alkaloids, ergolines
4

Publications

[Severe pleuropericarditis induced by long-term bromocriptin therapy, report of a case and review of the literature].
La Revue de medecine interne 2004 Apr;25;310-4 2004 Apr
Pleuropulmonary disease as a side-effect of treatment with bromocriptine.
Respiratory medicine 1998 Sep;92;1172-4 1998 Sep
Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.
The European respiratory journal 1997 Dec;10;2711-5 1997 Dec
Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
The European respiratory journal 1997 Dec;10;2898-901 1997 Dec
Suggestive evidence for bromocriptine-induced pleurisy.
The Netherlands journal of medicine 1996 Jun;48;232-6 1996 Jun
[Pleural effusion and severe edema of the lower limbs induced by bromocriptine].
La Revue de medecine interne 1996;17;680-3 1996

Powered by

  • ^
  • Contact
  • Cookies
  • About